Aesthetic and Reconstructive Markets

Aesthetic and reconstructive medicine, encompassing medical and surgical procedures and physician-administered products, is a dynamic area as a result of the overlap of medically reimbursed therapeutic procedures and out-of-pocket, cosmetic or purely aesthetic procedures. While there is a difference financially between the two areas of medicine, the medical and surgical procedures, as well as products, find overlapping benefits that blur the differences clinically. Physicians and medical product manufacturers have developed approaches to address post-traumatic or post-disease reconstruction that have demonstrated clear aesthetic benefits even in the absence of trauma or disease (in other words, more purely cosmetic).

Below is the distribution of product revenues in aesthetic and reconstructive medicine as the balance will change between from 2013 to 2018.

aesthetics-growth-segments

*Neuromodulators in aesthetic/reconstructive applications include Botox, Dysport, Xeomin, etc.

Source: MedMarket Diligence, LLC; Report #S710, “Global Markets for Aesthetic and Reconstructive Medicine, 2013-2018.”

The U.S. market continues to represent the biggest contributor to the global market for these products, as illustrated below.

aesthetics-regionals

Source: MedMarket Diligence, LLC; Report #S710, “Global Markets for Aesthetic and Reconstructive Medicine, 2013-2018.”

Leave a Reply